PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: antitrust
Innovators: Take a Leaf from the Generic Industry Book
No-one can accuse the European generic industry of indolence. It supplies huge quantities of medicines to European healthcare suppliers — its volume is estimated at around a half of the market. It is accounting for a growing share of marketing authorization applications in Europe. And its industry association, the EGA, has turned it from being [...]
Posted in Europe, Regulatory, healthcare Also tagged anti-competitive strategies, biosimilars, EC, EGA, EU, European Generics, generics, healthcare Leave a comment
Europe: Not Out of the Antitrust Woods Yet
Guest blog from Pharm Exec Europe’s Brussels correspondent, Reflector.
The new year has started with a grim reminder that last year’s heat over competition in the European pharmaceutical sector has not been dissipated by the winter’s frosts. Before January was a week old, the European Commission (EC) announced that it had opened a formal antitrust [...]
Posted in Europe, Global, Guest Blog, Regulatory Also tagged Competition, European Commission, European Union, Lundbeck, Neelie Kroes, Regulatory Leave a comment
The EC Admonishes European Pharma, European Pharma Celebrates
Despite the rhetoric, the climax of the European Commission’s antitrust investigations — instigated with dawn raids on the major pharma companies by EC Competition Commissioner Neelie Kroes last year — has been more of a whimper than a bang.
Pharm Exec Europe’s EU correspondent Reflector goes so far as to say “Big Pharma is not opening [...]
Posted in Global, Regulatory Also tagged anti-competitive, Brussels, EC, European Commission, European Union, generics, investigations, Neelie Kroes, Regulatory Leave a comment
European Commission Investigates J&J, Novartis